Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1,659,165
-
Shares change
-
+275,080
-
Total reported value, excl. options
-
$47,189,000
-
Value change
-
+$7,825,480
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$28.22
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2017
10 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2017.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,659,165 shares
.
Largest 10 shareholders include Parametric Portfolio Associates LLC (1,551,288 shares), World Asset Management Inc (89,362 shares), Sterling Capital Management LLC (7,323 shares), QUADRANT CAPITAL GROUP LLC (6,447 shares), GLENMEDE TRUST CO NA (3,076 shares), Hexavest Inc. (1,134 shares), Geneos Wealth Management Inc. (364 shares), McIlrath & Eck, LLC (106 shares), FTB Advisors, Inc. (65 shares), and MASSMUTUAL TRUST CO FSB/ADV (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.